Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Manuscript calls for collaborative approach to drug development
"We hope our recommendations will reposition comparative oncology canine trials as integral and parallel to human development" - Dr Chand Khanna.
Manuscript will further new initiatives to expand awareness of comparative oncology.

A new WSAVA-supported manuscript has highlighted the value of collaboration between the human and animal pharmaceutical and biotech sectors in drug development.

The manuscript follows a workshop on comparative oncology, hosted by the WSAVA's One Health Committee (WSAVA OHC) at its 2019 World Congress in Toronto. The workshop was led by researchers in human and animal medicine and was attended by academics and industry representatives working in cancer research.

Many cancers that afflict dogs also occur in humans, giving researchers the chance to improve lives by studying cancers and treatments in parallel. Delegates at the workshop included other members of the WSAVA OHC, academics and industry representatives working in cancer research.

In the manuscript, researchers outline new commercial perspectives on the value of closer relationships between the human and animal health pharmaceutical and biotech sectors, to deliver a ‘win/win’ for successful cancer drug development in humans and dogs.

Manuscript author Dr Chand Khanna, from the American College of Veterinary Internal Medicine (Oncology), commented: “We hope our recommendations will reposition comparative oncology canine trials as integral and parallel to human development and that this move will create opportunities for step-wise iteration and the improvements in the human cancer drug development path that are increasingly necessary.”

Dr Michael Lappin, chair of WSAVA One Health Committee, added: “The field of comparative oncology as part of cancer drug development stands out as a successful example of the One Health approach to medicine and this new manuscript presents a nuanced and novel strategy to deliver this translational opportunity.”

The authors and the WSAVA OHC plan to use the manuscript as a springboard for further new initiatives to expand awareness of comparative oncology. They also hope to drive forward its use to create a closer alignment of human and animal health pharma and biotech.

The manuscript, entitled ‘Delivering innovation to oncology drug development through cancer drug DISCO (Development Incentive Strategy using comparative oncology): Perspectives, gaps and solutions’, is published in the journal Annals of Medicine and Clinical Oncology

Become a member or log in to add this story to your CPD history

Hill's Vet Nurse Awards 2020 - get your nominations in!

News Story 1
 Hill's Pet Nutrition are reminding all veterinary nurses and veterinary practices to submit their entries for its 'Pet Slimmer of the Year' competition, 'Managing Weight with Excellence Competition' and the 'Senior Support Nurse of the Year Competition'.

The deadline for the 'Senior Support Nurse of the Year' competition closes on 6 September 2020, while the other competitions will remain open until 14 September 2020. All finalists will have the chance to win up to 500 worth of Love to Shop Vouchers.

To see full terms & conditions or to enter the awards click here

Click here for more...
News Shorts
Webinar highlights increasing threat of Angiostrongylus vasorum and other nematodes

CPD provider elearning.vet has launched a free webinar highlighting the increasing threat of Angiostrongylus vasorum and other nematodes to human and animal health. Hosted by parasitologist Dr Ian Wright, head of ESCAAP UK, the webinar also discusses the most effective treatment and prevention strategies.

Dr Wright said: "With surveys showing deworming frequencies below those recommended by ESCCAP and concerns surrounding over treatment of cats and dogs, there has never been a more important time to examine the importance of routine roundworm prevention. Without adequate control of Toxocara canis and Angiostronglyus vasorum, the impact on owners and their pets can be considerable."